KINGSLEY ALFRED D 4
4 · Oncocyte Corp · Filed Aug 17, 2022
Insider Transaction Report
Form 4
KINGSLEY ALFRED D
Director
Transactions
- Award
Option to Purchase Common Stock
2022-08-15+45,000→ 45,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (45,000 underlying) - Award
Common Stock, no par value
2022-08-15+10,000→ 404,111 total - Purchase
Common Stock, no par value
2022-08-15$0.97/sh+5,000$4,850→ 409,111 total - Purchase
Common Stock, no par value
2022-08-15$0.97/sh+5,000$4,850→ 414,111 total
Holdings
- 75,345(indirect: See footnote)
Common Stock, no par value
- 18,767(indirect: See footnote)
Common Stock, no par value
Footnotes (4)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.
- [F3]The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.
- [F4]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.